NEW YORK, April 29 /PRNewswire-USNewswire/ -- Blood fluoride levels were significantly higher in patients with osteosarcoma than in control groups, according to research published in Biological Trace Element Research (April 2009). Osteosarcoma, a rare bone cancer, occurs mostly in children and young adults.
Randhu and colleagues measured serum fluoride levels in three equal groups of age-matched and sex-matched patients. Group one had osteosarcoma, group two had non-osteosarcoma bone tumors, and group three had musculo-skeletal pain.(1)
"Mean serum fluoride concentration was found to be significantly higher in patients with osteosarcoma as compared to the other two groups," writes Randhu's team. "(T)his report proves a link between raised fluoride levels in serum and osteosarcoma," they write.
This reinforces a 2006 published Harvard study by Bassin showing a link between water fluoridation and osteosarcoma in young boys.(2)
A 1992 New Jersey Department of Health study shows osteosarcoma rates higher among young males in fluoridated vs. unfluoridated regions of New Jersey.(3)
More studies link fluoride to bone and other cancers but are downplayed or ignored by government officials.(4)(5)
Bone defects similar to bone cancer were detected in fluoridated Newburgh, NY children as early as 1955. Newburgh is home of the first human health fluoridation experiment begun in 1945.
According to Christopher Bryson in The Fluoride Deception, "A radiologist, Dr. John Caffey of Columbia University, called the defects 'striking' in their 'similarity' to bone cancer... and seen more than twice as frequently among boys in Newburgh as among boys in nonfluoridated Kingston [the control city]."(6)
In 2006, the prestigious National Research Council review of fluoride/fluoridation toxicology found
Page: 1 2 Related medicine technology :1
|SOURCE NYS Coalition Opposed to Fluoridation|
Copyright©2009 PR Newswire.
All rights reserved
. Viatronix V3D-Colon Utilized in Another Landmark Study2
. Another LNA-based RNA Inhibitor Enters Clinical Trials3
. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients4
. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer5
. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain6
. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma7
. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor8
. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-7969
. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD10
. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study11
. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression